Post-resection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma cannot be predicted by the 2019 World Health Organization classification

Post-resection prognosis of combined hepatocellular carcinoma-cholangiocarcinoma cannot be predicted by the 2019 World Health Organization classification

Background: Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CCA) has wide histologic diversity. This study investigated the prognostic impacts of cHCC-CCA histology according to the 2019 World Health Organization (WHO) classification. Methods: This retrospective observational study in...

Full description

Bibliographic Details
Main Authors:	Minjae Kim, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Gi-Won Song, Dong-Hwan Jung, Seung-Mo Hong
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	Asian Journal of Surgery
Subjects:	Combined tumor Stem cell feature Hepatic progenitor cell Hepatocellular carcinoma Cholangiocarcinoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958421001068

Similar Items

The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas
by: KyuHo Lee, et al.
Published: (2017-06-01)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
by: Sang Jae Noh, et al.
Published: (2012-12-01)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
by: Timo Alexander Auer, et al.
Published: (2023-05-01)

Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
by: Hai-Chun Zhang, et al.
Published: (2020-10-01)

Asbestos and Intrahepatic Cholangiocarcinoma
by: Giovanni Brandi, et al.
Published: (2020-02-01)

Case report: Toceranib as adjuvant chemotherapy in a dog with incompletely resected combined hepatocellular-cholangiocarcinoma
by: Sang-Won Kim, et al.
Published: (2023-01-01)

Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
by: Joon Hyuk Choi, et al.
Published: (2022-07-01)

Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma
by: Zhuanbo Yang, et al.
Published: (2024-03-01)

Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma
by: Hyo-Suk Ahn, et al.
Published: (2022-03-01)

Double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma
by: Yi-Hsuan Hu, et al.
Published: (2020-01-01)

Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma—Own Experiences and Review of the Literature
by: Laura Schwenk, et al.
Published: (2023-07-01)

Synchronous Hepatocellular Carcinoma and Cholangiocarcinoma in a Patient Transplanted for Cryptogenic Cirrhosis
by: B Geramizadeh, et al.
Published: (2014-07-01)

Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center
by: Lea Penzkofer, et al.
Published: (2023-01-01)

Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update
by: Florian Roßner, et al.
Published: (2023-01-01)

The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives
by: Johannes Eschrich, et al.
Published: (2023-01-01)

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
by: Tian MX, et al.
Published: (2019-06-01)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
by: Minjae Kim, et al.
Published: (2021-06-01)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
by: Jennifer Sammon, et al.
Published: (2018-02-01)

An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma✰
by: Marco P.A.W. Claasen, et al.
Published: (2023-06-01)

Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics
by: Ning Liu, et al.
Published: (2023-11-01)

A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
by: Takahiro Osuga, et al.
Published: (2022-03-01)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
by: Tao Wang, et al.
Published: (2020-12-01)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
by: Daw-Shyong Perng, et al.
Published: (2021-07-01)

Combined hepatocellular cholangiocarcinoma in hepatectomy specimens: A clinicopathologic analysis
by: Nayana Patil, et al.
Published: (2023-01-01)

Ataxia-telangiectasia and combined hepatocellular-cholangiocarcinoma: A case report
by: Tej P Singh, et al.
Published: (2023-01-01)

Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy
by: Yu J, et al.
Published: (2021-05-01)

Current update on combined hepatocellular-cholangiocarcinoma
by: Suresh Maximin, et al.
Published: (2014-01-01)

Deep Learning for the Pathologic Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer
by: Hyun-Jong Jang, et al.
Published: (2023-11-01)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
by: Ming-Chun Ma, et al.
Published: (2018-02-01)

Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor‐associated macrophages
by: Kun Ke, et al.
Published: (2023-10-01)

Cytological Comparison between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Image Analysis Software Using Touch Smear Samples of Surgically Resected Specimens
by: Sho Kitamura, et al.
Published: (2022-05-01)

An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation
by: Michael Svinarenko, et al.
Published: (2019-09-01)

Liver transplantation versus resection for patients with combined hepatocellular cholangiocarcinoma: A retrospective cohort study
by: Shizheng Mi, et al.
Published: (2023-10-01)

A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case
by: Qiang Fu, et al.
Published: (2022-03-01)

Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2022-06-01)

Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)
by: Marcus Bahra, et al.
Published: (2023-01-01)

Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma
by: Tomoyuki Satake, et al.
Published: (2023-07-01)

Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinoma
by: Granata Vincenza, et al.
Published: (2020-05-01)

Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
by: Wen-qiang Wang, et al.
Published: (2022-08-01)